Drug-induced cardiac mitochondrial dysfunction contributes to organ failure, and mitochondrial protection by drugs like carvedilol can mitigate toxicities such as those from doxorubicin.
No takes yet. Share an insight, caveat, or question.
Supports mitochondrial protection strategies against doxorubicin toxicity; leaves open optimal clinical integration pending prospective trials.
Pereira et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: